The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib.
Aki Morikawa
Research Funding - Bayer
Komal L. Jhaveri
Research Funding - Bayer
Sujata Patil
Research Funding - Bayer
Melanie Chen
Research Funding - Bayer
Edward McDonnell
Research Funding - Bayer
Deirdre A. Neville
Research Funding - Bayer
Fung Ming Mak
Research Funding - Bayer
Bolorsukh Gansukh
Research Funding - Bayer
Humm L. John
Research Funding - Bayer
Andrei Holodny
Research Funding - Bayer
Heiko Schöder
Research Funding - Bayer
Kathryn Beal
Research Funding - Bayer
Andrew David Seidman
Research Funding - Bayer